Sexton Biotechnologies
Indianapolis
About Sexton Biotechnologies
Sexton Biotechnologies announced today that it has raised $5 million in growth capital and is the first company incubated by Indianapolis-based Cook Regentec to secure outside investment capital and spin out as an independent biotechnology company. In addition to ongoing research and product development, Sexton Biotechnologies will expand and scale commercialization of its portfolio of container closure and media supplementation tools for cell and gene therapy bioproduction.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $5.0M
- Funding stage: M&A
- Last round: Series Unknown (Sep 2019)
- Website: sextonbiotechnologies.com
- Phone: +1 317.917.3450
Industries & Categories
Biotechnology
Canonical: https://fsome.com/organization/sexton-biotechnologies-47348 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.